Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Blair Fennimore"'
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 4, Pp 549-555 (2023)
Background and Aims: Anti-tumor necrosis factor agents (anti-TNFs) have become one of the primary medical therapies for Crohn’s disease (CD). We analyzed perceptions of infliximab and adalimumab in a large online community to better understand the
Externí odkaz:
https://doaj.org/article/78878866f6734017b911f31a677e6651
Autor:
Sara L. Coleman, C. Preston Neff, Sam X. Li, Abigail J.S. Armstrong, Jennifer M. Schneider, Sharon Sen, Blair Fennimore, Thomas B. Campbell, Catherine A. Lozupone, Brent E. Palmer
Publikováno v:
Gut Microbes, Vol 11, Iss 3, Pp 610-619 (2020)
Gaining a complete understanding of transmission risk factors will assist in efforts to reduce new HIV infections, especially within the disproportionally affected population of men who have sex with men (MSM). We recently reported that the fecal mic
Externí odkaz:
https://doaj.org/article/8bb7dbdcf0cc440d90a73715b826b7da
Autor:
John Galatowitsch, John P. Haydek, Waseem Ahmed, Blair Fennimore, Debbie Cheng, Calen A. Steiner, Benjamin Click, Mark E. Gerich, Alexis Oonk, Frank I. Scott
Publikováno v:
American Journal of Gastroenterology. 117:e649-e651
Autor:
Frank I. Scott, Kristine A. Kuhn, Mark E. Gerich, Blair Fennimore, Kenneth L. Jones, Andrew Stahly, Emilie Regner, Adam R. Lefferts, Alison E. Freeman, Becky O’Rourke
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Axial spondyloarthritis (axSpA) has strong connections with intestinal inflammation as occurs in Crohn’s disease (CD). However, the immunologic mechanisms that distinguish axSpA, CD, and those with features of both diseases (CD-axSpA) ar
Autor:
Kayla D. Battista, Jordi M. Lanis, Cynthia Ju, Sean P. Colgan, David J. Orlicky, Erica E. Alexeev, Blair Fennimore, Colin T. Shearn, Ian M. Cartwright, Rachael Kostelecky, Rachel Y. Gao
Publikováno v:
Mucosal immunology
Primary sclerosing cholangitis (PSC) is a progressive fibrosing cholestatic liver disease that is strongly associated with inflammatory bowel disease (IBD). PSC-associated IBD (PSC-IBD) displays a unique phenotype characterized by right-side predomin
Autor:
Jennifer M. Schneider, Blair Fennimore, Sara L. Coleman, C. Preston Neff, Catherine A. Lozupone, Sam X. Li, Sharon Sen, Thomas B. Campbell, Brent E. Palmer, Abigail J. S. Armstrong
Publikováno v:
Gut Microbes
article-version (VoR) Version of Record
Gut Microbes, Vol 11, Iss 3, Pp 610-619 (2020)
article-version (VoR) Version of Record
Gut Microbes, Vol 11, Iss 3, Pp 610-619 (2020)
Gaining a complete understanding of transmission risk factors will assist in efforts to reduce new HIV infections, especially within the disproportionally affected population of men who have sex with men (MSM). We recently reported that the fecal mic
Autor:
Edwin F. deZoeten, Daniel J. Kao, Kayla D. Battista, Robert W Isfort, Steven B. Colson, Alyson Yeckes, Mark E. Gerich, Simon Keely, Joseph C. Onyiah, Sean P. Colgan, Edward J. Hoffenberg, Brittelle E. Kessler, Blair Fennimore, Monica Murray, Mark A. Lovell
Publikováno v:
Hypoxia. 8:1-12
Background Inflammation results in significant shifts in tissue metabolism. Recent studies indicate that inflammation and hypoxia occur concomitantly. We examined whether circulating and tissue markers of hypoxia could serve as surrogate indicators o
Autor:
A. Stahly, M. E. Gerich, A. Brar, F. I. Scott, Kristine A. Kuhn, A. J. Berlinberg, Blair Fennimore
Newer ‘omics approaches such as metatranscriptomics and metabolomics allow functional assessments of the interaction(s) between the gut microbiome and the human host. In order to generate meaningful data with these approaches, though, the method of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0401e857c83d4a719264b7dec0ea89
https://doi.org/10.1101/2021.11.24.469968
https://doi.org/10.1101/2021.11.24.469968
Autor:
Emilie Regner, Blair Fennimore, Ana Brar, Frank I. Scott, Julie A. Reisz, Adam J. Berlinberg, Andrew Stahly, Alison E. Freeman, Kristine A. Kuhn, Mark E. Gerich
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut
Autor:
Richard A. Lirio, Dawn B. Beaulieu, Razvan Arsenescu, Tiffany Lin, Adam C. Stein, Wan Sun, Harisha Kadali, Jingjing Chen, Maria Rosario, Blair Fennimore, Sonya McKnight
Publikováno v:
Clinical Pharmacokinetics
Background and Objectives The safety of inflammatory bowel disease medications during lactation is of significant relevance to women of childbearing potential. Available data regarding the transfer of biologic agents for inflammatory bowel disease vi